Clinical Trial Update: Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a Personalized Cancer Vaccine (PCV) strategy in patients with solid tumors, specifically muscle-invasive bladder cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Adenocarcinoma
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Personalized Cancer Vaccine (PCV)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma | Phase 1 | Status: RECRUITING